
ã20210725å·ãã«ããŒã«ã®æ°ãã奎é·å¶åºŠãããŒã¹ãã»ãã·ãŒã³ãã¯ãã ã»ãŽãŒã²ã³ã«ãã£ãŠé»æ¢ãããã®ãïŒ
ãžã£ã¹ãã»ãšã³ãã¯ãŒã»ããŒã®èšäºãã

/ã¢ã³ããã¡ãéæ²³ãAzureãBEASTããã«ã»ã²ã€ããCOVID/çç©å µåš/ãã³ãããã¯ã芪æãªã人é¡ããã©ãŽã³ãã¡ããªãŒãèšé²ã®æ®¿å ãããŒçµ±åé貚ã·ã¹ãã (KIMS)ããã ã»ã€ã³ãã«ããã³ããªãŒã»ãŽãŒã²ã³ | å°äžåžä»€éšãå®è·è ãå°ç倧䜿ãGIA ã³ã³ãããŒã©ãŒãã¢ã«ãã¡ã·ã¹ãã ã³ã³ãããŒã©ãŒããªãµã»ã«ã | ãšãã«ã®ãŒåæãé»ã倪éœã®éšå£«å£ãã«ã€ã³ã®éå¥³å£ (ãœãã¢ã³ã®æªéã®è¡çµ±)ããã©ãŽã³ã®éšå£«å£: ãœãã¢ã³ã®è¡çµ±ãP3 ãããžãç¹èš± 666ããã¹ãã£ã€ã«ããã·ã¹ãã /ç ç©¶æãã¯ã¯ãã³é¢é£/ æçš¿è : jemgroup
å°çäžã§æé«ã©ã³ã¯ã®ã»ãã¥ãªãã£ã¯ãªã¢ã©ã³ã¹ãæã€ã°ããŒãã«ãªããžããªã®è²¬ä»»è ããã ã»ãŽãŒã²ã³ãæäŸããã2021幎7æ25æ¥ã®ç¶æ³ã¬ããŒãã®ã¢ããããŒãã®æéã§ãã
äŒè°ã«ã¯ããã€ãã®å®¹çè
ãåŸæãšããæ¹æ³ã§ãã£ã±ãã§ããã
圌ãã¯æš©åãåãæ»ãããã«éãé²ã¿ç¶ãã圌ãã倧奜ããªå èœããå¯çè«ã§ããç¶ããããã«æåãå°œãããŠããŸãã
ããã«ããããã ãšåœŒå¥³ã®ããŒã ã¯å é±éåžžã«å¿ãããªããŸãããããããããããšã«ã圌ãã¯å šäººé¡ã«ãšã£ãŠå£æ» çãªçµæã«ãªããããªãã£ãããšã«ãã¬ãŒãããããŸããã
ç¥ã®ã¿ã€ãã³ã°ãèŠéãããšã¯ã§ããŸãããããããªãç ç²ãæã£ãŠã§ãç§ãã¡ãæ¯é ããããšãããã£ãŒãã¹ããŒãã®ã²ãããããèŠéãããšã¯ã§ããŸããã

COVIDäœæŠã®èåŸã«ããç®ç
ãã ãšã¿ã³ã¯ã¯ãä»é±åœŒããè§£æããCOVIDäœæŠã«é¢ããçã®èšç»ãç§ãã¡ã«èª¬æããŠãããŸãããããã¯æ¬åœã¯äœãæå³ããã®ã§ããããïŒ
å
šäœåã¯ã©ã®ãããªãã®ã§ããããïŒ
ç§ãã¡ã¯ã©ããªæ°ããªå°çããéããã®ã§ããããïŒ
ãŸããããã¯ã»ãšãã©ã®äººã忥ããç¥ã£ãŠãããŠã€ã«ã¹ã§ã¯ãããŸãããCOVIDã¯ã¯ã¯ãã³æ¥çš®èå¥èšŒææžã®ç¥ã§ããããã¯ãéå»40幎é圌ããæ§ç¯ããŠããæ°ãã瀟äŒä¿¡çšå¥Žé·ã·ã¹ãã ã«ç§ãã¡å šå¡ãçµã³ä»ããããã®ãã®ã§ããããã¯å é±ã2021幎7æ22æ¥ã«çšŒåããäºå®ã§ããã
圌ãã¯çŸéãå®å šã«å»æ¢ããŠ100ïŒ ããžã¿ã«åããéè¡ã絶察çãªæš©åšã«ããäžçäžã®ãã¹ãŠã®æ¿åºãè§£äœããã€ããã§ããã
äžå€®éè¡ã§ããCDBCã¯ããããæœè¡ããããã®ãã¯ãããžãŒã§çµ¶å¯Ÿçãªå¶åŸ¡æš©ãæã¡ãŸãã誰ãã©ãã§äœ¿ã£ããã远跡ã§ããªããããçŸéããªãããªããã°ãªããŸããã§ããã
æ°ãã瀟äŒå¥Žé·ã·ã¹ãã ã§ã¯ãæ°ããæ¿çæœè¡ã·ã¹ãã ãšé£åããŠãäžçäžã®ããžã¿ã«æå·é貚ã远跡ããŸããããããäžççµæžãã©ãŒã©ã ã®åµèšè å ŒäŒé·ã§ããã¯ã©ãŠã¹ã»ã·ã¥ã¯ãããããšãã°èª°ã飿ã¯ã¬ãžãããåãåãããæ±ºå®ãã¹ããã€ãã³æ¿æš©ãšååããŠããçç±ã§ããããã¯ããã¹ãŠã®äººãšãã¹ãŠã®ãã®ãå¶åŸ¡ããBEAST ã·ã¹ãã ãšãªãã¯ãã§ããã
ãã æ°ã«ãããšããã®äŒè°ã®æç¹ã§äžç人å£ã®22.8%ãã¯ã¯ãã³IDèšŒææžãæ¥çš®æžã¿ã ãšããããã®éªæªãªèšç»ã®æ¬¡ã®ã¹ãããã¯ãäžé¢ãå šç±³åžæ°ã«COVIDãã¯ã¯ãã³ãæ¥çš®ã矩åä»ããæ³æ¡ãè°äŒã«æåºããããšã ã£ãã
ããã§æåããã°ãäžççã«å±éãããããšã«ãªãã
ãããããªãŒã¹ãã©ãªã¢ãšãã¥ãŒãžãŒã©ã³ãã§ã¯ãã§ã«ãã®è©Šéšãè¡ãããŠããã®ãèŠãããç§ã¯ã«ããããã®ãªã¹ãã«å ãããã

ããããããšã¯ã¯ãã³IDèšŒææžã人äœã«å°å ¥ããæ¹æ³
以äžã®åæ¹æ³ã«ããããããããã人äœã«ã€ã³ã¹ããŒã«ããããšãå¯èœã«ãªããŸãã
ãã¯ã¯ãã³ããæ³åãçµ¶ããã»ã©ã¯ã¯ãã³ã§ã¯ãããŸãããããããã¯å®éã«ã¯è¿œè·¡ mRNA ãªãã¬ãŒãã£ã³ã° ã·ã¹ãã ã®æ³šå°ã§ããæ³šå°ã«ã¯é žåã°ã©ãã§ã³ãå«ãŸããŠããããã¯ã¯ãã³ããšããŠåé¡ããããã¹ãŠã®æ³šå°ãšåæ§ã«ãæ°Žéãšã¢ã«ãããŠã ãå«ãŸããŠããããã¹ãŠäººäœã«ãšã£ãŠæ¯ç©ã§ãã
ãPCR æ€æ»ããPCR æ€æ»ã«ã¯ã°ã©ãã§ã³ ãªãã¬ãŒãã£ã³ã° ã·ã¹ãã ãå«ãŸããŠãããç¶¿æ£ã錻ã®ã§ããã ãé«ããšãããŸã§æ¿å ¥ãããšãè¡æ¶²è³é¢éã«çãŸããŸãã
ãç¹ã«ãã°ã©ãã§ã³ãå«ããã¹ãŠã®èªç©ºæ©å ã§ã¯ãã¹ã¯ãççšããŠãã ãããããããè¯ãèŽè¡ã§ããçç±ã¯ãè¡æ¶²è³é¢éã®éã®å±€ã35,000ãã£ãŒãã§ã¯ããã«èããªããããé£è¡äžã¯ããè匱ã«ãªãç æ°ã«ãªããããããã®ãããã¹ã¯ããã广çãŸãã¯ããæ©ãäœçšããå¯èœæ§ãããããã§ãã
ãã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ããã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ã«ãã°ã©ãã§ã³ã®ããç²åãå«ãŸããŠããŸãããããã®ããç²åã¯ãçãããŠã€ã«ã¹ãæ»ãã ãŠã€ã«ã¹ã䜿ã£ãŠææãããããã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ã¯ããããã®ç²åãäœå ã«åã蟌ãããã®åªããé ãèã§ããããŸãå¥ã®ææææ®µã§ãããããè¡ããšãå€ãã®é«éœ¢è ãçãå»¶ã³ãããªãåé¡ãçºçããããšãåãã£ãŠããŸããã圌ããæå³çã«æšçã«ããã¯ã¯ãã³æ¥çš®ãšã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãåããããããã«è人ããŒã ã«æŒã蟌ã¿ã宿¥œæ»ãããŸããã
ãã£ãŒãã¹ããŒãã¯ããã§ã«å¥åº·åé¡ãå
ç«ç³»ã®åé¡ãæ±ããŠããå€ãã®äººã
ãããããçãæ®ããªãã§ãããããšãååã«èªèããŠããŸãã
ããã¯ãã¹ãŠèšç»éãã§ããã匱è
ãæé€ããããã®æåã®æ®µéã«ãããŸããããã®åŸã圌ãã¯æé«ã®å¥Žé·ã«ãªã人ã
ãç¹å®ãå§ããããšãã§ããŸãã
ãã®ãããããã¯äœãããŸãã ?
ãããããã¯ãã¡ã€ã³ããŒã¿ããŒã¹ãã«ããŒã«å®å
šãªå¶åŸ¡æš©ãäžããŸãã
ãã®ã¡ã€ã³ããŒã¿ããŒã¹ãã«ããŒã¯ãããªãã®æèããã»ã¹ãå«ãããªãã®ç掻ã®ãã¹ãŠãå¶åŸ¡ã§ããå
éšã«ãã COVID ã¹ãã£ããŒãæäœã§ããŸãã
ããã¯ããªã¢ãŒãã³ã³ãããŒã«ã§ãããããçã®ãã©ã³ã¹ãã¥ãŒãããºã -ãŸã³ãé»ç€ºé²ã·ã¹ãã ã§ãã圌ãã¯ãã€ã§ããã©ããªçç±ã§ããããªãã®é»æºããªãã«ããããšãã§ããŸããããªãã®å éšã«ãããããéããããšã¯ã§ããŸããã

- ãã«ã»ã²ã€ããCNN 4/23/20
ã¢ã©ããå·ã§èšŽèšãèµ·ãããã â CDCå éšåçºè
ãã£ãŒãã¹ããŒãã¯ã¯ã¯ãã³ã«ããå®éã®æ»äº¡è æ°ãé ãããšããŠããããæè¿ã¢ã©ããå·ã§ã¢ã¡ãªã«ã®æåç·ã®å»åž«ãã蚎èšãèµ·ãããã
ã¢ã¡ãªã«ã®æåç·ã®å»åž«ããã³ããã¯ã¯ãã³ã®ç·æ¥äœ¿çšåæžãæ±ããŠé£éŠèšŽèšãèµ·ãã â PaulCraigRoberts.org CDCã®å éšåçºè ã¯ãç±³åœã§ã®æ»äº¡è æ°ãçŽ45,000äººãšæšå®ããŠããã
ãããããã®æ°åã¯ãã£ã1ã€ã®ããŒã¿ããŒã¹ããåŸããã®ãªã®ã§ãå®éã®æ°åã¯45,000人ããã¯ããã«å€ãããããŠã45,000äººã®æ»äº¡ãã¯ã¯ãã³ã«ãã£ãŠåŒãèµ·ãããããšå ±åããå éšåçºè ã¯ã3æ¥éã®æéã«èšåããŠããã ãã®ããã ã
ããã«å ããŠãVAERSïŒä»»æã®ã·ã¹ãã ã§ããããšã«ããåžžã«éåžžã«äœãå²åãå ±åããŠããïŒã«å ããŠããã®æ å ±ãèšé²ããŠããããŒã¿ããŒã¹ãããã«3ã€ããã
ç·æ¥æ²»çå®€ãæºæ¯ã«ãªã£ãŠããã®ã¯æ°åã³ããæ£è ã§ã¯ãªããå¯äœçšãåããŠããæ£è ã§ãã£ã±ãã ãšããå»åž«ããã®å ±åãããããå€ãåºãŠããã
ãããã®æ°åã¯ããããèšç®ã«ã¯å«ãŸããŠããªãããŠã€ã«ã¹ã¯èæ±ã«çãŸããããç§ãã¡ãç®ã«ããŠããæãäžè¬çãªå¯äœçšã®1ã€ã¯ç¥çµé害ã ã
å人çã«ã¯ãã©ã®ã·ã¹ãã ã§çºè¡šãããçµ±èšãããŸãä¿¡çšããŠããªãã
倧åŠã§åŠãã å¯äžã®äŸ¡å€ããããšã¯ãçµ±èšã§åãã€ããããç©èªãå€ãããããããšãããã«ç°¡åããšããããšã ãç§ã¯ãçµ±èšã¯ãã¹ãŠå€§å¹
ã«éå°è©äŸ¡ããŠãããšæãåŸåãããã
ç£ã®å»å°
ãç£ã®å»å°ãã¯ãå®æææžãé¢ä¿ãããšããã§ããç£ã·ã¹ãã ã¯ãåè¿°ã®äž»èŠãªããŒã¿ããŒã¹ä¿æè ã§ããæ°ãã AI ç¥ãšãªãã¯ãã§ããããã®ç®çã¯ã人é¡ãåã³å¥Žé·åããããšã§ããããä»åã¯ãã¹ãã£ã€ã«ãå®¶ãéå¶ãããã©ãŽã³ ãã¡ããªãŒã§ã¯ãªãããã©ã㯠ãµã³æŽŸé¥ã«ãã£ãŠè¡ãããŸããã
æ°ãã奎é·å¶åºŠã¯ããã¯ããšãã¯ãã®ç掻ã®ããããåŽé¢ãã³ã³ãããŒã«ããŸãããã¯ãã¬ãã«ã§ã¯ããã¹ãŠã®æ¿åºã«åã£ãŠä»£ããããã¹ãŠã®æ°Žãšé£æã®äŸçµŠãé»åç¶²ã倩æ°ãªã©ãã³ã³ãããŒã«ããŸãã
ãã¯ãã¬ãã«ã§ã¯ãAI èšç®æ©ãå®è¡ããŠãå人ã®çç©åŠç掻åãå人é¢ä¿ã賌買掻åãªã©ãç£èŠããçµæããå°ãåºãããå人ã®ç€ŸäŒçä¿¡çšã¹ã³ã¢ã決å®ããŸãããããŠãããªããååšãã¹ããã©ãããæ±ºå®ããŸãã
ããã¯ãŸã£ããæ°ããæ å ±ã§ã¯ãããŸãããã圌ããå®éã«ããŒã¹ãã®å®è£ ã«ã©ãã»ã©è¿ã¥ããŠãããã¯ææ ®ãã¹ãããšã§ãã
ãã©ã㯠ãµã³æŽŸãšãã¹ãã£ã€ã«ã掟ã®éãã®è©³çްã«ã€ããŠã¯ãç§ã®æçš¿ã2 ã€ã®é女å£ã®ç©èª: äžçå¶èŠããããæŠãã®æè ãã¡ (ãã ãŽãŒã²ã³ - ããŒã 5)ããåç §ããŠãã ããã
ç¹èš±666
ããŒã¹ãã«ã¯æ¬ç©ã®ç¹èš±ãããããã¡ããã666ããåã蟌ãŸããŠããŸãã
以äžãåç
§ããŠãã ãããããã¯ãW02020060606 â èº«äœæŽ»åããŒã¿ã䜿çšããæå·é貚ã·ã¹ãã ããšåŒã°ããŠããŸãã
2021幎7æ22æ¥ã®Tank's Live at 5 Reportããã¹ã¯ãªãŒã³ã·ã§ãããæ®ããŸãããããã¯ãç¹èš±ã®URLã§ãããWIPO â Search International and National Patent Collectionsãã«ãäžæãªç¹èš±åºé¡ããšè¡šç€ºãããŠããããã§ããæè¿æ³šç®ãããŠããããšãèãããšãããã»ã©é©ãããšã§ã¯ãããŸããã
å é±ã®Live at 5ã§ã®ã¿ã³ã¯ã®å ±åãèšãæãããšããã®èšç»ã¯ãäŒæ¥ãæ¹å€ããã人éã®DNAã®ç¹èš±ãååŸãããã®æš©å©ãææããããšãèš±å¯ãã2013å¹Žã®æé«è£å€æã®å€æ±ºã«ãã£ãŠå¯èœã«ãªã£ãã圌ãã¯ããã©ã³ã¹ãã¥ãŒãããºã ãšåŒã°ããæ°ããã«ããŽãªãŒã®åæçåœäœãäœãåºãããšã§ããã¹ãŠã®äººéçæš©å©ã奪ãããšããŠããã
ãããã£ãŠããåœã¯ã¯ãã³ããæ¥çš®ããããšã§ã人éã® DNA ã 5G åšæ³¢æ°ãš ãMRNA (ã ã«ã)ãªãã¬ãŒãã£ã³ã° ã·ã¹ãã ããšçµã¿åããããŠã人㮠DNA ã倿ããããã®æ°ããããã©ã³ã¹ãã¥ãŒãããºã ãã«ããŽãªã«ååé¡ãããããšãæå³ãããŠãããšæšæž¬ã§ããŸãã

BLO Bing My Credit Troux SharePointã ã ãµã€ãäœæã ã¿ã€ã ã·ãŒãã¯ã©ã€ã¢ã³ã åçã¢ã...ããŒã·ã¥SharePoint... ãŠã€ã IP ããŒã¿ã«Â ã¡ãã¥ãŒ ããã³ãã¹ã³ãŒã äžæãªç¹èš±åºé¡
Covid-19  UpdateX PPM ã¿ã€ã ã·ãŒã æ°èŠã¿ã Adwrap
ãã«ã ENGLISH ãã°ã€ã³ ãã£ãŒããã㯠æ€çŽ¢ ⌠ãã©ãŠãº v ããŒã« ⟠èšå® ãã®ä»ã®ãæ°ã«å ¥ã WIPO

http://unitednetwork.nund
1196bee3/SPECIAL-REPORT-with-Steffen-Row-7262021
wo2020060606 èº«äœæŽ»åããŒã¿ãçšããæå·é貚ã·ã¹ãã
PATENTSCOPEã¯2021幎7æ27æ¥ïŒç«ïŒ12:00 PM CESTã«ã¡ã³ããã³ã¹ã®ããæ°æéå©çšã§ããªããªããŸãã
ããŒã¿ã«ã¡ãã¥ãŒ
ããã³ãã¹ã³ãŒã
Covid-19 UpdateX
ãã«ã ãã°ã€ã³
ãã£ãŒããã㯠æ€çŽ¢ é²èЧ ããŒã« èšå®
1. wo2020060606 - 身äœã䜿ã£ãæå·é貚ã·ã¹ãã
掻åããŒã¿
PCTæç® ããŒã¿ å 容 ã¯ã¬ãŒã å³é¢ ISR/WOSA/A172al åœå 段é ç¹èš±ãã¡ããªãŒ éç¥ ææž å ¬éçªå· å ¬éæ¥
å ¬éæ¥ 2020.03.26
PC/2018/038084
åœéåºé¡æ¥
20.06.2019
0080 20/08 2012.1 0080 20/32 2012.1
ããšãŒã« 2006.8.32 006030/02 2012.3
ãŽãŒã³ 2008.3.8
CPC
ã°ãŒã 3/0 ã²ã³ 3/0454 03/0472
ãŽãŒã³ 3/08 0060 20/18 006020/321
åé¡ããã£ãšèŠã éä¿¡ ããŒããªã³ã¯ æ©æ¢°ç¿»èš³
èº«äœæŽ»åããŒã¿ã䜿çšããæå·é貚ã·ã¹ãã Pr systÚme de cryptomonnaie utilisant des données d'activité corporel
å³1
ãã€ã¯ããœãããã¯ãããžãŒã©ã€ã»ã³ã·ã³ã°
SVUS
ã¯ã³ã»ãã€ã¯ããœããã»ãŠã§ã€ ã¯ã·ã³ãã³å·ã¬ããã¢ã³ã
90052-6300, US
çºæè
ABRAMSON, Dustin
JOHNSON, Joseph Edwin, JR.
ãšãŒãžã§ã³ã
MINHAS, Sandip S
ãã§ã³ã»ãŠã§ã€ãã£ã³ãã³ã©ã¹
HINOJOSA, Brianna L
ãã«ã 㺠ããŒã³J
WONG, Thomas S
ãã§ã« ãããšã«
ãŠã£ãªã¢ã C.
ãã£ã¿ãŒãžãŒïŒã¢ãŒãã³C
JARDINE, John S.
GOLDSMITH, Micah R
TRAN, K
N, Kimberly
ãã¬ã¹ïŒãšãã¬ãŒ
åªå ããŒã¿
18/138,518 2018.08.21 Us
åºçèšèª
https://patentscope.wipo.int/search/en/detail.jsf?docid=W
æŠèŠ
[EN]ã
ãŠãŒã¶ãŒã«æäŸãããã¿ã¹ã¯ã«é¢é£ããäººäœæŽ»åã¯ãæå·é貚ã·ã¹ãã ã®ãã€ãã³ã°ããã»ã¹ã§äœ¿çšãããå¯èœæ§ãããããµãŒããŒã¯ãæ€ç¥ããããŠãŒã¶ãŒã®èº«äœæŽ»åã«é¢é£ããã¿ã¹ã¯ããŠãŒã¶ãŒã®ããã€ã¹ã«æäŸããããšãã§ããããŠãŒã¶ãŒã®ããã€ã¹ã«éä¿¡å¯èœã«çµåãããæå·é貚ã·ã¹ãã ã¯ãèº«äœæŽ»åããŒã¿ãæå·é貚ã·ã¹ãã ã«ãã£ãŠèšå®ããã1ã€ä»¥äžã®æ¡ä»¶ãæºãããã©ãããæ€èšŒããããšãã§ããã
æå·é貚ã·ã¹ãã ã¯ãèº«äœæŽ»åããŒã¿ãæå·é貚ã·ã¹ãã ã«ãã£ãŠèšå®ããã1ã€ãŸãã¯è€æ°ã®æ¡ä»¶ãæºãããã©ãããæ€èšŒãããµãŒããŒãšéä¿¡å¯èœã«çµåããããŠãŒã¶ãŒã®ããã€ã¹å ã®èº«äœæŽ»åããŒã¿ãeã§ãããŠãŒã¶ãŒã«æå·é貚ãä»äžããããŠãŒã¶ãŒã®ããã€ã¹ã«éä¿¡å¯èœã«çµåãããããŸãã¯ããã€ã¹ã«å«ãŸããã»ã³ãµãŒã¯ããŠãŒã¶ãŒã®èº«äœæŽ»åãæ€åºããããšãã§ããã
èº«äœæŽ»åããŒã¿ã¯ããŠãŒã¶ã®æ€åºãããèº«äœæŽ»åã«åºã¥ããŠçæãããããŠãŒã¶ãŒã®ããã€ã¹ã«éä¿¡å¯èœã«çµåãããæ¬çºæã®æå·é貚ã·ã¹ãã ã¯ãèº«äœæŽ»åããŒã¿ãæå·é貚ã·ã¹ãã ã«ãã£ãŠå®çŸ©ããã1ã€ãŸãã¯è€æ°ã®æ¡ä»¶ãæºãããã©ãããæ€èšŒããæå·é貚ã606&tab=PCTBIBLIOãšããŠãå ¬éãããŠãããŠãŒã¶ãŒã«å²ãåœãŠãããšãã§ããã
ããªã¹ãæçã®æºæã¯ã©ã®ããã«åœãŠã¯ãŸãã®ã§ãããã ?
ãã ã«ãããšããã©ãã¯ã»ãµã³æå£ã¯ãç¥ãåãå ââãçå®ãä¿¡ãããåéãã人ã ãç¡ååããèšç»ããã¹ãŠæºåããŠããã
ãŸã³ãã®éãé²ãã§éžã°ãªã人ãªã誰ã§ãç¡ååãããã®ã ããã
圌ãã¯ãããã®äººã
ãããªããªãããšãå¿
èŠãšããŠããããããäžçé貚ãªã»ããã»ããã°ã©ã ã®çã®ç®çã§ãããå°ãªããšã圌ãã®ããŒãžã§ã³ã§ã¯ãèæžã®æºæã«åœè£
ãããŠããã
圌ãã®èšç»ã®ãã®éšåãå®å
šã«çè§£ãããã©ããã¯èªä¿¡ããããŸããã
圌ãã¯ããŸã詳ãã話ããŠãããªãã£ãããã§ãã
ãããã圌ãã®äŒè©±ã«åºã¥ããç§ã®èŠè§£ã¯ããã§ãã
ãã©ãã¯ãµã³ã¯ãçã®ä¿¡è
ããéšããŠãç£ã®å»å°ãåããã«ä»£ããã«æºæããããšããæ¡ä»¶ãä»ããããããšãã§ãããšèããŠããŸãã
圌ãã¯ãçã®ä¿¡è
ãã«ããã¡ãããã®ç¹æš©ãåŸãã«ã¯å³æ Œãªç§å¯ä¿æå¥çŽ (NDA) ã«çœ²åããå¿
èŠããããšåãããã®ããã«ã¯ç¹å®ã®æéã«æ¥µç§ã®ç¥ç§çãªå Žæã«çŸããå¿
èŠããããŸãã
å®éã«ã¯ãçŸããã ãã§ç«ã¡å»ãããšã¯ãããŸããã
奎é·ãšããŠå£²ãããã ? ãã®å Žã§æ®ºãããŠã蚌æ ãé ãããã«ãã€ãªã¹ã©ããžã«å€ããããã§ãããã

11æéç®ã«ã€ããŠè©±ããŸããã !
ãã©ã㯠ãµã³æå£å šäœãããã®ããŒã¹ã ã·ã¹ãã ãå©çšããŠäººé¡ãåã³å¥Žé·åããããšããŠããŸããããªããªããå¥çŽã®æŽæ°ã¯å®çŸããªãã ãããšããã£ãŠããããã§ãã
ããããããç§ãã¡ã圌ãã®æ°ããã·ã¹ãã ã«å·»ã蟌ãŸããã°ãç§ãã¡ã¯çœ ã«ã¯ãŸãããã®ããã°ã©ã ã«å±ãããããªããªãã§ãããããããŠãããã¯å é±ãå±éãããæºåãã§ããŠããŸããã
ãã ãšã¿ã³ã¯ã¯ãèªåãã¡ãå®éã«ã©ãã»ã©é²ãã§ãããããã£ãŠããªãã£ããšèªããŸããã幞éã«ããç¥ã®æçã«ããããã ãšåœŒå¥³ã®ããŒã ã¯å é±ãã¡ããã©éã«åãããã«ç¹ãšç¹ãçµã³å§ããå±éåã«ãããè§£äœããããšãã§ããŸããã
泚:ãã ãèšåããå¥çŽã¯ã2018 幎 12 æã«çµäºãã 3000 幎åã®ææ°ã®å¥çŽã§ãããšç§ã¯èããŠããŸããå¥çŽã®è©³çްã«ã€ããŠã¯ãç§ã®æçš¿Kane is Abel ãåç §ããŠãã ããã
ãã ã«äœããèµ·ãã£ãŠãããšèŠåããã®ã¯äœã ã£ãã®ãïŒ
ãã æ°ã¯ãæ¯ãè¿ã£ãŠã¿ããšäœããèµ·ãã£ãŠããå
åããã£ããšè¿°ã¹ãã
äŸãã°ããã€ãã®å®¹çè
ãã¡ã¯äŸç¶ãšããŠçµæžã厩å£ããç¶ããã€ããã§ããïŒããã¯åœŒãèªèº«ã«ã圱é¿ããã ããïŒããããŠãã£ãŒãã¹ããŒãïŒéã®æ¿åºïŒã®åšå²ã§ã¯å·šé¡ã®å ±é
¬ãæåŸ
ããŠãããšããåãåã³åºãŸã£ãŠããã圌女ã¯ãä»åºŠã¯åœŒããã©ããããããæåŸ
ããŠããã®ãçåã«æã£ãŠããã
åœãã€ãã³æ¿æš©ãéå¶ããè»ã®å°è»ãã¡ã¯ããèšé²ã®æ®¿å ããååããããšããæ¹åãããæ³åŸãArchives.govã®ã·ã¹ãã ã«éä¿¡ããã¢ãŒããã¹ãã¯ã鱿«ãŸã§åŸ ã€ããåœä»€ãåºãŠãããšãã ã«äŒããã
æ¹åãããæ³åŸã®å ¬åŒèšé²ãã¢ãŒããã¹ãã«ãã£ãŠå ¬éãããã®ã¯ã5幎以äžã¶ãã®ããšã ãšç§ã¯æããïŒãã ã¯èšé²ã®æ®¿å ã«ã¢ã¯ã»ã¹ã§ããæè¿æ¹åãããå·è°äŒãªã©ã®éèŠãªè³æãéä¿¡ããŠãããïŒã
ãã®åŸã圌女ã¯ä¿å¥å±ããé»è©±ãåãããã¯ãèŠåãåããã
鱿«ä»¥éããã«ã»ã²ã€ããä¿å¥å±é·ã«å°±ä»»ããäºå®ãªã®ã§ãå
šå¡ãåŸ
æ©ããŠãããšã®ããšã ã£ãããŸãã«ç§ãã¡ãå¿
èŠãšããŠããã®ã¯ã人é¡è殺ã«å·çãããµã€ã³ãã¹ããã®å±ã®è²¬ä»»è
ã«ãªãããšã ããªããŠãã£ãïŒ
ããã§ããã¹ãŠã¯ãã«ã»ã²ã€ããšåœŒã®ããŒã¹ããã·ã³ã«çµã³ã€ãå§ããæçµçã«åœŒå¥³ã¯èª¿æ»ããããŒã¹ãã Microsoft Azure ã¯ã©ãŠãã³ã³ãã¥ãŒãã£ã³ã°ã·ã¹ãã ã§ãã¹ããããŠããããšãçºèŠããŸããã
äœè«ã§ããã圌女ã¯ãèªåã®ã·ã¹ãã ã§ãã Key Integrated Monetary System (KIMS) ã䜿çšããŠäººã
ã®éè¡å£åº§ã«çŽæ¥è³éãæå
¥ããããšããããã€ã³ã¹ããŒã«ãšééããããã¯ããç¶ããçç±ãçªãæ¢ããŸããã
ããã¯ãAzure ãäžçäžã®ãã¹ãŠã®éè¡ã·ã¹ãã ã«å¯Ÿããã·ã¹ãã 管çè
æš©éãæã£ãŠããããã§ãã
泚:ã®ã¶ããæ¥ç¶ãããå€ä»£ã®éæ²³ããŒã¿ã«ã¯ã ãã€ãŠã¯ã·ãªãŠã¹ B ãééããæ¬¡ã« ã¢ã³ããã¡ãéæ²³ãééããããšãã§ããŸããã
ã¢ã³ããã¡ãã«ã¯éæ²³ã³ã¢ããããã¢ã»ã³ã·ã§ã³ ãµã€ã¯ã«äžã«èºæç¶ã«å転ããŠå€©ã®å·éæ²³ã³ã¢ã«æ¥ç¶ããŸããçŸåšãå°çãšã¢ã³ããã¡ãã®ãšãã«ã®ãŒã®ã®ã¶åšèŸºã®ãã®é åã§ã¯ãèšå€§ãªéã®æŽ»åãé²è¡äžã§ãã
ã®ã¶ ããŒã¿ã«ã¯å°çã®ããŒã ãã£ã¯ã©ã®å Žæã§ããã第 4 ã²ãŒãããã³ç¬¬ 4 次å ã«ã察å¿ããŠããŸãããã®ããŒã¿ã«ã¯ãã¹ãã£ã³ã¯ã¹ã倧ãã©ããããããã³å°çã³ã¢ãéããšãå®å®ã®èšæ¶ãææã®ã¡ã¢ãª ãã³ã¯ (ããã³åœ¢æ 圢æå Ž) ã«è§£æŸãããèšé²ã®ããŒã«ãã®å Žæã«ãçžäºæ¥ç¶ãããŠããŸãã
ããã«ãããæäœéã®ç¬¬ 4 DNA éã®æŽ»æ§åã«ããããææãšéã®è»¢çèšæ¶ãã人éã«å©çšå¯èœã«ãªããŸãã
éæ²³ã®äžå¿ãšã¢ã³ããã¡ãã®éæ²³ã³ã¢ã¯äº€å·®ããŠããŸãã
ãããå¥ã®èšãæ¹ã§èšããšãç§ãã¡ã¯ã€ãã«ç§ãã¡ã®åµé ã®æ¬æ¥ã®æ žããã¹ãŠã®çµ±åã®äžå¿ç¹ãšäº€å·®ããŠãããšããããšã§ãã
倩ã®å·ãš ã¢ã³ããã¡ãéæ²³ã®éã«éè·¯ãäœããªãŒãã©ãã©ãããã©ãŒã ããããŸãããªãµã»ã¬ããŒããšãã«ã®ãŒçµ±åãã¢ã»ã³ã·ã§ã³çšèªé â ã¢ã³ããã¡ãéæ²³
ããŒã¹ãã·ã¹ãã ã¯ããçµããïŒ
ãã ã¯ãæãæ©ã解決ç㯠IT ã¢ã¯ã»ã¹ãå®å šã«é®æããããšã ãšå€æããããã®ããã«ã¯ãäžçäžã®ãã€ã¯ããœããã®æãé¢ãããã¹ãŠã®ã·ã¹ãã 管çããã³ã»ãã¥ãªã㣠ãã©ã«ããŒã鮿ããå¿ èŠããã£ãã
圌女ã«ãããšããã£ãŒã ã¹ããŒãã¯å®éã«ãã®äºæ
ãå芳ããŠãããã
圌女ãããŒã¿ããŒã¹ãä¹ã£åãã®ã黿¢ããããšã¯ã§ããªãã£ããšããã
ããŒã¿ããŒã¹ã¯çŸåšãå®å
šã«ä¿ç®¡ãããŠããŸãã
ããŒã¿ããŒã¹ã®æš©éã¯ãã ãšåœŒå¥³ã®ããŒã 以å€ã«ã¯èª°ã«ãäžããããŠããŸããã
ããŒã¿ããŒã¹ã¯ã°ããŒãã« ãªããžã㪠ã·ã¹ãã ã®é£ã«ç§»åãããããããã£ãŒã ã¹ããŒãã¯ãã¯ãé»åã°ãªãããæ°Žè·¯ããªãŒãã£ã³ãªã©ã«å¯Ÿããå®å šãªé»åå¶åŸ¡ãè¡ããŸããã
ãã¹ãŠã®ã·ã¹ãã ã®åºæ¬æ©èœã¯ãã¹ãŠç§»è¡ããã圌女ã¯ãã§ã«è§£äœãéå§ããŠããŸããAmazonãGoogleãAppleãOracle Cloud ãµãŒããŒã䜿çšããŠããä»ã®å€ãã®ãµã€ããå é±ã®æšææ¥ã«åæ¢ããå¿ èŠããããŸããã圌女ã¯ãããã®ãµã€ããéãå Žãæããªãããã«ãããã£ãããã§ãã
ãã¯ã€ãããŠã¹ãéå¶ããè»ã¯çµ±å¶ã§ããŠããªãïŒ
è»ãä¿¡é ŒããŠãã ããïŒã圌ããæ¯é æš©ãæ¡ã£ãŠãããå ±ååœãæã£ãŠãããã§ããããåãæ°ãããŸãã
åœé²ç·çã®æå°çç«å Žã«ãããããã®æªéã¯ã人é¡å²äžæå€§ã®ã¯ãŒãã¿ãŒãšå¥Žé·åèšç»ã«é¢äžããŠããŸã (å°ãªããšãçŸåšã®ã¿ã€ã ã©ã€ã³ã§ã¯)ã
å°çã®ãã« ã²ã€ããããŒã¯ã·ã£ãŒ ããµãŠã§ã€ã®ãŠã£ãªã¢ã ããã§ããããžã§ãŒãž ãœãã¹ããã®ä»ã®ã€ã®ãªã¹ã®èªå·±äžå¿çãªæªå ãã¡ã¯ããããã®ããããè±éãã¡ãšãšãã«ããã®å奎é·åèšç»ã«å šé¢çã«é¢äžããŠããŸããããªããšæ®é ·ãªåè«ã§ãããã
å°è»ãã¡ã«ã«ã«ãã¯èšªããã®ãïŒ
ãããã®å²æ ¢ã§éªæªãªå°è»ãã¡ã¯ããã£ãŒãã¹ããŒãã§å€§æµè¡ããŠãããã®æåãªCOVIDãæ»ãåµåžã®åéãå»¶æãç¶ããŸããã
ã€ãã«å°è»ãã¡ã¯åœã®çŸéãé ããŸãããæäžãã¡ã«æ¬åœã®èšç»ãäœã§ããããåããããšãã§ãããæäžãã¡ã窮å°ã«è¿œã蟌ãããã§ããã
ãã®èšç»ãšã¯ã圌ãå šå¡ã瀟äŒçã«æäœããããŸã³ãã«ããããšã ã£ãã®ã§ããæçµçã«ãããã®ãã«è ãã¡ã¯ãæ»ç¥ã²ã€ããæè¿è³Œå ¥ãããã¹ãŠã®èŸ²å°ã®ãã€ãªã¹ã©ããžè¥æã«ããªãã§ãããã
ãã©ãã¯ãµã³ã®ããã«ã©ãã ãé·ãéç¡åã§åããŠããæäžãã¡ããäžçäžã«ããŸããŸãªé貚ã§åœæãé ããããšãããšããäºæ ã¯ããã«æªåããã
æŽè³ããã奎é·ãã¡ã¯ããŸãããŠãéšãããããšã«æ°ã¥ãå§ããã«éããªããããã§å°è»ãã¡ã¯å¥ã®èª¬ãæŒãéãããšãããæšææ¥ã«éå§ããäºå®ã ãã宿ã¡ã³ããã³ã¹äžãªã®ã§åµåžã®åéã·ã¹ãã ãžã®ã¢ã¯ã»ã¹ããŸã æ©èœããŠããªããŠãå¿é ããå¿ èŠã¯ãªããéææ¥ãŸã§ã«ã¯ç¢ºå®ã«ã¢ã¯ã»ã¹ã§ããããã«ãªãããšå°è»ãã¡ã¯èšã£ãã
æããã«æŽè³ã¯è«çã«åããéææ¥ã«åœŒãã¯ã·ã¹ãã ãå®å šã«æ¶ããããšãç¥ã£ãã®ã ïŒæäžãã¡ã¯å¥Žé·äž»äººã®ããã«ç¡åã§åãç¶ããã®ã ãããïŒ
éææ¥ã«çŸéãšã·ã¹ãã ãæ©èœããªãã£ãåŸããã¯ã€ãããŠã¹ã®ã·ãã¥ãšãŒã·ã§ã³ã«ãŒã ã§ããŒã¹ãã·ã¹ãã å šäœãæ¶æ» ããããšã«é¢ããå€§èŠæš¡ãªäŒè°ãéãããŸããã
ãã ã¯ïŒåœŒå¥³ã¯ãã®å Žã«ããªãã£ãã®ã§ãäœãèµ·ãã£ãã®ãèããã®ã§ããããïŒãåºåžè ã®å€§åã¯å€§èŠæš¡ãªå奎é·åããã°ã©ã ã«ãããèªåãã¡ã®åœ¹å²ãã»ãã®å°ãããç¥ããªãã£ããšäŒããŸããã
ãã®ç®çã®ããã«ãã¹ãŠãåºååãããŠããããã圌ãã¯èªåãå®éã«é¢äžããŠããå šäœåãèŠãããšãã§ããŸããããããã圌ããç§ãã¡ãšåœŒãã«äœãããã€ããã ã£ããã«ã€ããŠãæçãéãŸãå§ããŠããŸãã
åºåžè
ã®äžã«ã¯ãç¹ã«å€±ç€Œã§æã£ãŠããå°è»ã 1 人ããŸããã
ãã®å°è»ã¯æããã«ããŒã¹ã ã·ã¹ãã ã«ã€ããŠæã詳ããç¥ã£ãŠããŠãè»ã«æãåºããšã©ããªããããã®å¥³ (ã€ãŸããã ) ã«æããŠãããšèšããŸããã
圌ã¯éšäžã«ããã ãæãŸããããã«å·è¡å®ãåŒã¶ããåœä»€ããŸãããããããéšäžã¯ãã ã®æ¹ãéçŽãé«ãã®ã§ããã¯ã§ããªããšåœŒã«æ³šæããŸããããããšåœŒã¯ããããã£ã! ããŒããåŒã¹!ããšèšããŸããã
ããŒãã¯ã€ãã«é¥èœããã®ãïŒ
ãã®å Žåã®ããŒããšã¯ãããã©ãã¯ã»ãµã³ã»ãããžãããŸãã¯ãP3ãããžã»ã°ã«ãŒããã®ããšã§ãããšã«ãããããŒãã§ã¯ããã©ãã¯ã¹ã¯ãªãŒã³ïŒç§ã«ã¯çè§£ã§ããŸããïŒã䜿ã£ãŠãã³ããåµãšåœæãæ£åœåããããšããŸãããããããã«ããŠã倱æããŸããã
倱æãæåŠãã¢ã¯ã»ã¹æåŠãè©æ¬ºæªéã®ããã¢ã«ãŠã³ããééããããšããã¡ãã»ãŒãžãå±ãç¶ããŸããã
æçµçã«ããã®P3ãããžã»ã°ã«ãŒãã¯ããã ã远ãè©°ãããšããå°è»ã®æ±ºæã®åœ±é¿ã¯è² ããªããšäŒããŸããã圌ãã¯å°è»ãå©ããŸãããå°è»ã¯ç¬ããŒã£ã¡ã§ãã
ããŒãã®åãçµç¹ãP3ãããžã¯ãå°è»ãã¡ãå
šå¡åº§ã£ãŠåœä»€ãåŸ
ã£ãŠããéã«äŒè°ãéããŸããããã®äŒè°ã®çµæãP3ãããžã¯è²æ©ããŸããã
圌ãã¯ä»é±ãã ã«é£çµ¡ãåãäºå®ã§ãã
æåŸã«
ç§ãšããŠã¯ã圌ãã®èšãããšã¯äœäžã€ä¿¡çšã§ããªããã圌ããè²æ©ããã€ããããªããšæãã
圌ããæã
ã«äœãå¥ã®ããšã仿ããŠããã®ã¯ééããªãã
ããŒã¹ããåããããšã§ãæ¬åœã«éšãã«ãªã£ãã
ä»é±ããã¹ã¯ççšçŸ©ååã«åãã倧ããªåããåã³èŠãããæé«è£ã¯äŒæ¥ãã¯ã¯ãã³æ¥çš®ã匷å¶ããããšã¯åæ³ã ãšå®£èšããã蟲家ã¯äŸç¶ãšããŠäœç©ã廿£ãããšè
ããã圌ãã¯ãããå®è¡ã«ç§»ããŠããïŒ
è²æ©ã¯èŠåœãããªããããããã®éã ã
å ã匷ããªãã°ãªãã»ã©ãå ±åŸ©ã匷ããªããç§ãã¡ã¯ä»ãæé«ã®æã§ãããææªã®æã§ããããåã¯æªã«åã€ããç§ãã¡ã¯ãã®éã«åŸããªããã°ãªããªããååã¯é¿ããããªããããã©ãã¯ã»ãµã³æå£ã¯ç¢ºå®ã«åŒ±äœåããŠãããç¹ã«ãã³ã·ãŒã圌ãã®ç¢çã®ç¢ãããªãæžã£ãŠããããšã«æ°ä»ããŠãããããšãé¡ãã
åããã·ãŒã«ãã匵ãïŒåšæ³¢æ°ãé«ãä¿ã¡ããŸã³ãã«æ°ãã€ããïŒ
ãã®éªæªãªé°è¬ã«é¢ããå¥ã®èª¬æã«ã€ããŠã¯ããã£ãµãªã³ã»ãªãŒã¹ãã£ã³ã»ãã£ãããšã®ã€ã³ã¿ãã¥ãŒã«é¢ããç§ã®é¢é£èšäºãéæ³ã®ãŠã€ã«ã¹ã«ããæ°ãã奎é·å¶åºŠã®ç·šæããåç §ããŠãã ããã
ãã ã¯éå»ã®ã©ã€ããã©ãŒã¹ã®é話ã§ããã£ãµãªã³ã®èª¬æã¯åœŒå¥³ãç¥ã£ãŠããèšç»ãšããäžèŽããŠãããšã³ã¡ã³ãããŸããã
ããžã£ã()